These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2730851)

  • 1. Graves' ophthalmopathy.
    Smith RJ
    Br J Ophthalmol; 1989 May; 73(5):322. PubMed ID: 2730851
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of antibodies in Graves' ophthalmopathy].
    Molnár I; Balázs C
    Orv Hetil; 1991 Sep; 132(38):2097-100. PubMed ID: 1923482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of Graves' ophthalmopathy.
    Gorman CA; Bahn RS
    Dev Ophthalmol; 1989; 20():1-7. PubMed ID: 2687045
    [No Abstract]   [Full Text] [Related]  

  • 5. [Muscle antigens recognized with autoantibodies in patients with Graves' ophthalmopathy].
    Adler G
    Endokrynol Pol; 1992; 43(1 Suppl):1-61. PubMed ID: 1345558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to eye muscle and orbital fibroblasts in the pathogenesis of thyroid-associated ophthalmopathy.
    Weightman D; Perros P; Sherif I; Janat F; Kendall-Taylor P
    Exp Clin Endocrinol; 1991 May; 97(2-3):197-201. PubMed ID: 1915634
    [No Abstract]   [Full Text] [Related]  

  • 8. Graves' ophthalmopathy.
    Wall JR; Henderson J; Strakosch CR; Joyner DM
    Can Med Assoc J; 1981 Apr; 124(7):855-62, 866. PubMed ID: 7011529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiopathogenesis of Graves' disease.
    Karasek M; Lewinski A
    Neuro Endocrinol Lett; 2003; 24(3-4):161-6. PubMed ID: 14523350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
    Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
    J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of smoking on Graves' disease with or without ophthalmopathy and nontoxic nodular goiter in Taiwan.
    Chen YL; Chang TC; Chen CJ
    J Formos Med Assoc; 1994 Jan; 93(1):40-4. PubMed ID: 7915579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
    De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' ophthalmopathy.
    Bistriceanu M; Cergă A; Lichiardopol-Răducanu C
    Oftalmologia; 1993; 37(2):99-103. PubMed ID: 8507632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis and treatment of Graves' ophthalmopathy.
    Jones IR
    Postgrad Med J; 1987 Sep; 63(743):731-3. PubMed ID: 3444795
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid stimulation-blocking antibody and Graves' ophthalmopathy.
    Kubota S; Fukata S; Amino N; Miyauchi A
    Thyroid; 2006 Jul; 16(7):708. PubMed ID: 16889500
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
    Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
    Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor autoantibodies recognizing two different epitopes on the TSH receptor: lack of relationship to patient age, sex, and ophthalmopathy.
    Jaume JC; Prummel MF; Wiersinga WM; McLachlan SM; Rapoport B
    Thyroid; 1993; 3(4):291-5. PubMed ID: 7509670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.